Skip to content

Clinical trials

Observational Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Observational Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20063
20083
20092
20101
20115
20122
20131
20141
20162
20181
20195
20203
20212
20225
20236
20243
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting13
Unknown status10
Active, not recruiting6
Not yet recruiting4
Terminated4
Suspended2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
M.D. Anderson Cancer Center3
Royal Marsden NHS Foundation Trust3
Gynecologic Oncology Group2
Memorial Sloan Kettering Cancer Center2
Rigshospitalet, Denmark2
Travera Inc2
AGO Study Group1
Abramson Cancer Center at Penn Medicine1
Affidea Nu-med Center of Oncological DIagnostics and Therapy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms58
Uterine Cervical Neoplasms39
Ovarian Neoplasms29
Endometrial Neoplasms25
Vaginal Neoplasms21
Fallopian Tube Neoplasms13
Uterine Neoplasms12
Esophageal Neoplasms11
Stomach Neoplasms10
Breast Neoplasms9

Trials

Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.